I agree that this site is using cookies. You can find further informations here.
X
Touat, Mehdi
249  results:
Search for persons X
?
1

REVOLUMAB: A phase II trial of nivolumab in recurrent IDH m..:

Picca, Alberto ; Touat, Mehdi ; Belin, Lisa...
European Journal of Cancer.  202 (2024)  - p. 114034 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Management of Entrapped Temporal Horn: Literature Review an..:

RISI, Ahmed AL ; MATHON, Bertrand ; TOUAT, Mehdi..
Clinical Neurology and Neurosurgery.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Mutant IDH inhibitors induce lineage differentiation in IDH..:

Spitzer, Avishay ; Gritsch, Simon ; Nomura, Masashi...
Cancer Cell.  42 (2024)  5 - p. 904-914.e9 , 2024
Link: https://doi.org/10.1016/..
 
?
4

The biological significance of tumor grade, age, enhancemen..:

van den Bent, Martin J ; French, Pim J ; Brat, Daniel...
Neuro-Oncology.  , 2024
Link: https://doi.org/10.1093/..
 
?
5

Epstein-Barr Virus and immune status imprint the immunogeno..:

Baron, Marine ; Labreche, Karim ; Veyri, Marianne...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
6

INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY..:

McBain, Catherine ; Mellinghoff, Ingo K ; van den Bent, Martin J...
Neuro-Oncology.  25 (2023)  Supplement_3 - p. iii6-iii6 , 2023
Link: https://doi.org/10.1093/..
 
?
7

LTBK-06. IMPACT OF VORASIDENIB TREATMENT ON MUTANT IDH1 OR ..:

Wen, Patrick ; Mellinghoff, Ingo ; van den Bent, Martin...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v310-v311 , 2023
Link: https://doi.org/10.1093/..
 
?
8

CTIM-25. EO2401 PEPTIDE IMMUNOTHERAPY + NIVOLUMAB +/- BEVAC..:

Reardon, David ; Idbaih, Ahmed ; Vieito, Maria...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v67-v68 , 2023
Link: https://doi.org/10.1093/..
 
?
9

PATH-12. CONTEMPORARY MOLECULAR LANDSCAPE, SURVIVAL, AND PR..:

Ghosh, Hia ; Patel, Ruchit ; Woodward, Eleanor...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v169-v169 , 2023
Link: https://doi.org/10.1093/..
 
?
10

NIMG-60. PATTERNS OF PROGRESSION IN GLIOBLASTOMA PATIENTS U..:

Rochand, Adrien ; Baldini, Capucine ; Touat, Mehdi
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v199-v199 , 2023
Link: https://doi.org/10.1093/..
 
?
11

Exploring the mechanism of 18F‐fluorodopa uptake in recurre..:

Cobes, Nina ; Tran, Suzanne ; Mathon, Bertrand...
European Journal of Neurology.  31 (2023)  1 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
12

CTNI-51. A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF VORASID..:

Cloughesy, Timothy ; Mellinghoff, Ingo ; van den Bent, Martin...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v86-v87 , 2023
Link: https://doi.org/10.1093/..
 
?
13

In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectr..:

Di Stefano, Anna Luisa ; Nichelli, Lucia ; Berzero, Giulia...
Neurology.  100 (2023)  1 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
14

Lynch syndrome: influence of additional susceptibility vari..:

Vibert, Roseline ; Hasnaoui, Jasmine ; Perrier, Alexandre...
European Journal of Human Genetics.  31 (2023)  9 - p. 1078-1082 , 2023
Link: https://doi.org/10.1038/..
 
?
15

A new subtype of diffuse midline glioma, H3 K27 and BRAF/FG..:

Auffret, Lucie ; Ajlil, Yassine ; Tauziède-Espariat, Arnault...
Acta Neuropathologica.  147 (2023)  1 - p. , 2023
Link: https://doi.org/10.1007/..
 
1-15